DDX3P1: A Drug Target / Disease Biomarker (G100133180)

Target Name: DDX3P1

NCBI ID: G100133180

DDX3P1

Other Name(s): DEAD-box helicase 3 pseudogene 1 | DDX3YP1

DDX3P1: A Drug Target / Disease Biomarker

DDX3P1, also known as decorin, is a protein that is expressed in the brain and other tissues of the body. It is a member of the tight-cuff family of proteins, which are characterized by their ability to form a cuff or bundle around other proteins. This family of proteins is thought to be involved in various physiological processes, including cell signaling, tissue repair, and inflammation.

One of the unique features of DDX3P1 is its ability to interact with several different proteins, including casein, a protein that is found in many cell types. This interaction between DDX3P1 and casein has been shown to play a role in the regulation of various cellular processes, including cell signaling, neurotransmitter release, and intracellular signaling.

In addition to its interaction with casein, DDX3P1 has also been shown to interact with several other proteins, including the protein known as FBN1. FBN1 is a protein that is expressed in the blood vessels, and it is thought to be involved in the regulation of various physiological processes, including blood clotting and vascular remodeling.

The interaction between DDX3P1 and FBN1 has been shown to be important for the regulation of blood clotting. In addition, it has also been shown to play a role in the regulation of cell signaling, neurotransmitter release, and intracellular signaling.

One of the potential applications of DDX3P1 as a drug target or biomarker is its ability to interact with casein and other proteins, which suggests that it may be a useful target for the development of new therapies for various diseases. For example, the regulation of cell signaling and neurotransmitter release by DDX3P1 may be important for the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

In addition to its potential therapeutic applications, DDX3P1 also has the potential to be a valuable biomarker for certain diseases. The regulation of cell signaling and neurotransmitter release by DDX3P1 may be important for the diagnosis and treatment of conditions such as depression, anxiety, and other mood disorders.

In conclusion, DDX3P1 is a protein that is expressed in the brain and other tissues of the body. It is a member of the tight-cuff family of proteins and has been shown to interact with several different proteins, including casein and FBN1. The interaction between DDX3P1 and these proteins has been shown to play a role in the regulation of various cellular processes, including cell signaling, neurotransmitter release, and intracellular signaling. As a result, DDX3P1 may be a potential drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand the role of DDX3P1 in these processes and to develop new therapies based on its unique properties.

Protein Name: DEAD-box Helicase 3 Pseudogene 1

The "DDX3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets